Mga Batayang Estadistika
CIK | 1591077 |
SEC Filings
SEC Filings (Chronological Order)
February 14, 2014 |
Adcock Ingram Holdings Limited Adcock Ingram Holdings Limited (Incorporated in the Republic of South Africa) Registration number 2007/016236/06 Share code: AIP ISIN: ZAE000123436 (“Adcock Ingram”) CFR Pharmaceuticals S. |
|
February 14, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM CB/A TENDER OFFER/RIGHTS OFFERING NOTIFICATION FORM (AMENDMENT NO. 5) Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to file this Form: Securities Act Rule 801 (Rights Offering) o Securities Act Rule 802 (Exchange Offer) ý Exchange Act Rule 13e-4(h)(8) (Issuer Tender Offer) o E |
|
February 14, 2014 |
Not for release, publication or distribution, in whole or in part, in or into or from any jurisdiction, where to do so would constitute a violation of the relevant laws of such jurisdiction. |
|
February 7, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM CB/A TENDER OFFER/RIGHTS OFFERING NOTIFICATION FORM (AMENDMENT NO. 4) Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to file this Form: Securities Act Rule 801 (Rights Offering) o Securities Act Rule 802 (Exchange Offer) ý Exchange Act Rule 13e-4(h)(8) (Issuer Tender Offer) o E |
|
February 7, 2014 |
Not for release, publication or distribution, in whole or in part, in or into or from any jurisdiction, where to do so would constitute a violation of the relevant laws of such jurisdiction. |
|
February 7, 2014 |
Adcock Ingram Holdings Limited EX-99.I1A 2 cfrcba4ex991a0206.htm Adcock Ingram Holdings Limited (Incorporated in the Republic of South Africa) Registration number 2007/016236/06 Share code: AIP ISIN: ZAE000123436 (“Adcock Ingram” or “the Company”) CFR Pharmaceuticals S.A. (Incorporated in the Republic of Chile) Chilean Tax ID: 76.116.242-K Securities Regulation Chilean Registry number: 1067 Share Code on the Santiago Stock Exch |
|
January 21, 2014 |
Not for release, publication or distribution, in whole or in part, in or into or from any jurisdiction, where to do so would constitute a violation of the relevant laws of such jurisdiction. |
|
January 21, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM CB/A TENDER OFFER/RIGHTS OFFERING NOTIFICATION FORM (AMENDMENT NO. 3) Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to file this Form: Securities Act Rule 801 (Rights Offering) o Securities Act Rule 802 (Exchange Offer) ý Exchange Act Rule 13e-4(h)(8) (Issuer Tender Offer) o E |
|
January 21, 2014 |
EX-99.I-1(A) 2 cfrcbaex991a0117.htm Adcock Ingram Holdings Limited (Incorporated in the Republic of South Africa) Registration number: 2007/016236/06 Share code: AIP ISIN: ZAE000123436 (“Adcock Ingram” or “the Company”) CFR Pharmaceuticals S.A. (Incorporated in the Republic of Chile) Chilean Tax ID: 76.116.242-K Securities Regulation Chilean Registry number: 1067 Share code on the Santiago Stock E |
|
December 16, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM CB/A TENDER OFFER/RIGHTS OFFERING NOTIFICATION FORM (AMENDMENT NO. 2) Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to file this Form: Securities Act Rule 801 (Rights Offering) o Securities Act Rule 802 (Exchange Offer) ý Exchange Act Rule 13e-4(h)(8) (Issuer Tender Offer) o E |
|
December 16, 2013 |
FINAL Adcock Ingram Holdings Limited (Incorporated in the Republic of South Africa) Registration number: 2007/016236/06 Share code: AIP ISIN: ZAE000123436 (“Adcock Ingram” or “the Company”) CFR Pharmaceuticals S. |
|
December 16, 2013 |
Not for release, publication or distribution, in whole or in part, in or into or from any jurisdiction, where to do so would constitute a violation of the relevant laws of such jurisdiction. |
|
November 19, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM CB/A TENDER OFFER/RIGHTS OFFERING NOTIFICATION FORM (AMENDMENT NO. 1) Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to file this Form: Securities Act Rule 801 (Rights Offering) o Securities Act Rule 802 (Exchange Offer) ý Exchange Act Rule 13e-4(h)(8) (Issuer Tender Offer) o E |
|
November 19, 2013 |
Adcock Ingram Holdings Limited Adcock Ingram Holdings Limited (Incorporated in the Republic of South Africa) Registration number 2007/016236/06 Share code: AIP ISIN: ZAE000123436 (“Adcock Ingram” or “the Company”) NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF APPLICABLE LAW OR REGULATION DISTRIBUTION OF CIRCULAR TO ADCOCK INGRAM SHAREHOLDERS IN RESPECT OF A SCHEME OF ARRANGEMENT All terms in upper case in this announcement that are not defined herein shall bear the same meanings to those set out in the Circular. |
|
November 19, 2013 |
EX-99.II-1(A) 3 exhibit9911a-18.htm FOR IMMEDIATE RELEASE CFR Pharmaceuticals S.A. (Incorporated in the Republic of Chile) Chilean Tax ID: 76,116,242-K Securities Regulation Registry number: 1067 Share code: CFR ISIN: CL0001762831 DISTRIBUTION OF CIRCULAR TO ADCOCK INGRAM SHAREHOLDERS IN RESPECT OF A SCHEME OF ARRANGEMENT AND POSTING OF CFR COMBINED PROSPECTUS AND PRE-LISTING STATEMENT Santiago, C |
|
November 15, 2013 |
EX-99.1 2 cfr-ex991.htm Adcock Ingram Holdings Limited (Incorporated in the Republic of South Africa) Registration number: 2007/016236/06 Share code: AIP ISIN: ZAE000123436 (“Adcock Ingram” or “the Company”) CFR Pharmaceuticals S.A. (Incorporated in the Republic of Chile) Chilean Tax ID: 76.116.242-K Securities Regulation Chilean Registry number: 1067 Share code on the Santiago Stock Exchange: CFR |
|
November 15, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form F-X APPOINTMENT OF AGENT FOR SERVICE OF PROCESS AND UNDERTAKING A. Name of issuer or person filing (“Filer”): CFR Pharmaceuticals S.A. B. (1) This is [check one] ý an original filing for the Filer o an amended filing for the Filer (2) Check the following box if you are filing the Form F-X in paper in accordance with Regul |
|
November 15, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM CB TENDER OFFER/RIGHTS OFFERING NOTIFICATION FORM Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to file this Form: Securities Act Rule 801 (Rights Offering) o Securities Act Rule 802 (Exchange Offer) ý Exchange Act Rule 13e-4(h)(8) (Issuer Tender Offer) o Exchange Act Rule 14d |
|
November 15, 2013 |
Not for release, publication or distribution, in whole or in part, in or into or from any jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction FOR IMMEDIATE RELEASE CFR Pharmaceuticals S. |